CBG: The Cannabinoid Against Colon Cancer?
New research suggests that CBG, one of the lesser known cannabinoids found within cannabis and hemp, can help treat and prevent colon cancer.
When it comes to cannabinoids, it is THC and CBD that tend to take the limelight. However, whilst these two are the most prolific beneficial cannabinoids, they are by far not the only ones. It is important to remember that cannabis contains over 80 unique cannabinoids, all with their own interactions and benefits. It is why research into cannabis takes so long – there is simply so much going on!
Recently, one lesser known cannabinoid, cannabigerol, or CBG for short, has made the news as it has been discovered it could act to prevent colon cancer. CBG is a non-psychoactive cannabinoid that has already been shown to help relieve the symptoms of such ailments as glaucoma and irritable bowel syndrome.
This latest bit of research comes to us courtesy of the US National Institute of Health, an organisation that has previously focused on trying to research and discover negative aspects of cannabis instead of looking at its benefits. They published their research in the Oxford journal Carcinogenesis, which details how they administered CBG to animals to observe its effects on xenograft tumours as well as chemically-induced colon carcinogenesis.
It was found that CBG interacted with specific targets, including the tumorous cells, inhibiting their growth and progression.
Normally, research like this would suggest that it is still early days, and that much more comprehensive testing is required; but the researchers here go as far as to say that CBG should seriously be considered transnationally in the prevention and treatment of colon cancer. Considering this is research from the National Institute of Health, it is a pretty big deal.
It is worth noting that due to the fact that CBG is non-psychoactive, it is not considered an illegal substance in most countries, and can be grown in abundance in legal industrial hemp. In fact, it tends to be found in naturally higher concentrates within industrial hemp than it does in most strains of cannabis.
It just goes to show how we have only just scratched the surface when it comes to the health potential of cannabinoids, and how much more there really is to discover. What we can say for sure is that this is good news - news that will hopefully lead to more research and practical cures.